Holen Sie sich die Stockscreener-App
72.01
0.12%
-0.09
Handel nachbörslich:
72.04
0.03
+0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
Dexcom (DXCM) chair’s 10b5-1 sale leaves 382,482 shares held - Stock Titan
DexCom Faces Product Safety Incident, Stock Drops 4% - GuruFocus
Dexcom warns of scrapped glucose sensors being resold - MedTech Dive
Dexcom warns patients as stolen glucose sensors hit the market - Reuters
DexCom (DXCM) Alerts Customers About Stolen G7 Sensors - GuruFocus
Dexcom uncovers theft of scrapped product, notifies potentially impacted users - marketscreener.com
Dexcom Inc. stock (US2521311074): diabetes-tech player draws fresh fund flows and cautious optimism - AD HOC NEWS
Dexcom recalls stolen G7 sensors sold by unauthorized vendor - Investing.com Canada
Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users - Business Wire
Dexcom’s SWOT analysis: stock faces competitive headwinds in 2026 By Investing.com - Investing.com India
Dexcom’s SWOT analysis: stock faces competitive headwinds in 2026 - Investing.com UK
DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings Signal Potential Upside - DirectorsTalk Interviews
Dexcom stock (US2521311074): earnings beat and fresh institutional interest keep CGM story in focus - AD HOC NEWS
DXCM to launch Dexcom Flex CGM system for type 2 diabetes in Germany - MSN
DexCom Inc. stock outperforms competitors on strong trading day - MSN
How Dexcom Inc. (DXCM) Affects Rotational Strategy Timing - Stock Traders Daily
Does DexCom’s (DXCM) Flex Launch in Germany Hint at a Broader CGM Access Strategy Shift? - simplywall.st
Elliott strikes Dexcom board settlement after taking stake - MSN
6-Day Rally Sends DexCom Stock Up 25% - Trefis
Dexcom: A Medical Platform Play Gaining From AI, Not Disrupted By It (NYSEARCA:DEXC) - Seeking Alpha
DexCom Flex Launch Targets Wider Type 2 Market With Valuation Upside - Yahoo Finance
DexCom, Inc.Common Stock (NQ: DXCM - The Chronicle-Journal
Analysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share Recovery - Insider Monkey
1DXCM.MI Stock Price, Quote & Chart | DEXCOM INC (BIT:1DXCM) - ChartMill
DexCom Stock Rockets 24% With 5-Day Winning Streak - Trefis
Dexcom stock (US2521311074): diabetes-tech player draws attention after Q1 earnings beat - AD HOC NEWS
DexCom Might Finally Be Cheap Enough (NASDAQ:DXCM) - Seeking Alpha
Here's why DexCom (DXCM) is a strong momentum stock - MSN
[144] DEXCOM INC SEC Filing - Stock Titan
Dexcom stock (US2521311074): Insider sale adds focus on shares - AD HOC NEWS
The DexCom Stock Turnaround Is Showing Real Signs of Life - Yahoo Finance
Here's Why DexCom (DXCM) is a Strong Momentum Stock - Yahoo Finance
DexCom Inc. stock underperforms Friday when compared to competitors - MSN
Dexcom stock (US2521311074): Insider sale and sharp price jump put CGM specialist in focus - AD HOC NEWS
Dexcom (NASDAQ: DXCM) legal chief sells 1,700 shares under 10b5-1 plan - Stock Titan
Elliott to get two board seats at Dexcom ahead of investor day - MSN
DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany - Zacks Investment Research
CCORF Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $82 - Moomoo
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $85 - Moomoo
Devon Energy Corp stock (US2521311074): earnings momentum and oil price tailwinds in focus - AD HOC NEWS
A Look at DexCom Inc (DXCM) After 5.6% Gain -- GF Value $102.05 vs Price $65.09 - GuruFocus
Dexcom Inc. stock (US2521311074): buyback, 2030 targets and activist deal fire up DXCM - AD HOC NEWS
DexCom : Operations and Innovation Committee - marketscreener.com
DexCom Is Maintained at Buy by Canaccord Genuity - Moomoo
A Potential Turnaround Stock In Digital Healthcare - Good Money Guide
Here's why you should hold DexCom stock in your portfolio for now - MSN
DexCom (DXCM) Introduces Dexcom Flex for Type 2 Diabetes Patients - GuruFocus
DexCom Price Target Cut to $80.00/Share From $100.00 by B of A Securities - Moomoo
Dexcom stock (US2521311074): Analyst moves follow Elliott deal and new long-term targets - AD HOC NEWS
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany - 01net
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces - GuruFocus
DexCom Stock Jumps As 2030 Targets Ignite Bullish Trading - StocksToTrade
Dexcom Reveals Flex CGM for Type 2 Diabetes Patients - Medical Product Outsourcing
DexCom, Inc. Stock 12‑Month Price Target Cut to $82.28, Implies 34% Upside - TradingView
Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo - Yahoo Finance
DexCom Expands CGM Access in Germany With New Dexcom Flex System for Type 2 Diabetes - Moomoo
0.08%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):